HRA Pharma appoints OTC Medical as distributor in the Netherlands in a bid to expand further in the Dutch market
As a result of recent growth and restructuring, HRA Pharma selects OTC Medical as their official distributor in the Netherlands.
HRA Pharma believes there is further strong growth potential in the Dutch market with the hope that the appointment will encourage this expansion.
Consumer healthcare company HRA Pharma has today announced the appointment of OTC Medical, a marketing and sales organisation for over-the-counter products including medicine, as its exclusive distributor in the Netherlands. This comes after recent growth and restructuring of HRA Pharma alongside plans to expand its business further in the Dutch market.
As of January 2021, OTC Medical will take full responsibility of retail customers for the sales and distribution of HRA Pharma’s consumer healthcare brands ellaOne, NorLevo and Compeed in the Netherlands. OTC Medical will succeed Jan Willem Bartels of 2E’s Selfcare who as the marketing and sales consultant for HRA Pharma in the Netherlands has successfully grown the business over the past four years.
OTC Medical is one of the fastest growing companies for self-care medicines and is within the top 10 suppliers for drugstores, pharmacies, supermarkets and health shops in the Netherlands.
Rene Leeuwenburgh, Director of OTC Medical, says, “We are proud to be adding another three high quality brands to our existing portfolio of brands which offer solutions to consumer healthcare problems or needs. Due to our specialisation in the Dutch market, we believe we can give HRA Pharma a strong presence across the Netherlands.”
Martyn Hilton, Chief Global Commercial Officer of HRA Pharma, says, “OTC Medical will be an excellent fit for HRA Pharma’s culture as they are a small, entrepreneurial company with an excellent growth track record. We target significant growth in the Netherlands and appointing OTC Medical as our exclusive distributor will help us get there.”